glp 1 agonist diarrhea semaglutide Semaglutide is a FDA-approved GLP-1 receptor used to improve blood sugar GLP-1 Diarrhea: Causes, Treatment &

In 2024 the Food and Drug Administration added cardiovascular risk as a reason to be prescribed the GLP-1 drug Wegovy, grounded in results from a major trial that showed fewer heart attacks, strokes, and cardiovascular deaths in adults with obesity or overweight and established heart disease

Combining physical activity with a balanced diet is recommended for maximum weight management effectiveness

However, this approach involves ethical and documentation considerations that you should discuss thoroughly with your healthcare provider

This is a significant concern for businesses who might be adversely affected by lower volumes of food sales to obese individuals

Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)